BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 9893958)

  • 1. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
    Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
    Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
    Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
    Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the radiochemical design of antibodies with a metabolizable linkage for target-selective radioactivity delivery.
    Arano Y; Wakisaka K; Akizawa H; Ono M; Kawai K; Nakayama M; Sakahara H; Konishi J; Saji H
    Bioconjug Chem; 1998; 9(4):497-506. PubMed ID: 9667952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reassessment of diethylenetriaminepentaacetic acid (DTPA) as a chelating agent for indium-111 labeling of polypeptides using a newly synthesized monoreactive DTPA derivative.
    Arano Y; Uezono T; Akizawa H; Ono M; Wakisaka K; Nakayama M; Sakahara H; Konishi J; Yokoyama A
    J Med Chem; 1996 Aug; 39(18):3451-60. PubMed ID: 8784442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo instability of reduction-mediated 99mTc-labeled monoclonal antibody.
    Sakahara H; Saga T; Endo K; Hattori N; Hosono M; Kobayashi H; Shirato M; Yamamuro T; Toyama S; Arano Y
    Nucl Med Biol; 1993 Jul; 20(5):617-23. PubMed ID: 8358347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of a metabolizable ester bond in radioimmunoconjugates.
    Arano Y; Wakisaka K; Mukai T; Uezono T; Motonari H; Akizawa H; Kairiyama C; Ohmomo Y; Tanaka C; Ishiyama M; Sakahara H; Konishi J; Yokoyama A
    Nucl Med Biol; 1996 Feb; 23(2):129-36. PubMed ID: 8868284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of hydroxamamide-based tetradentate ligands as a new class of thiol-free chelating molecules for 99mTc radiopharmaceuticals.
    Xu LC; Nakayama M; Harada K; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Arano Y
    Nucl Med Biol; 1998 Apr; 25(3):295-303. PubMed ID: 9620636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of internally labeled monoclonal antibodies as a gold standard: comparison of biodistribution of 75Se-, 111In-, and 125I-labeled monoclonal antibodies in osteogenic sarcoma xenografts in nude mice.
    Koizumi M; Endo K; Watanabe Y; Saga T; Sakahara H; Konishi J; Yamamuro T; Toyama S
    Cancer Res; 1989 Apr; 49(7):1752-7. PubMed ID: 2924318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between in vitro binding activity and in vivo tumor accumulation of radiolabeled monoclonal antibodies.
    Sakahara H; Endo K; Koizumi M; Nakashima T; Kunimatsu M; Watanabe Y; Kawamura Y; Nakamura T; Tanaka H; Kotoura Y
    J Nucl Med; 1988 Feb; 29(2):235-40. PubMed ID: 3162255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of 186/188Re-labeled antibody (A7) for radioimmunotherapy with rhenium(I) tricarbonyl core as a chelate site.
    Ogawa K; Kawashima H; Kinuya S; Shiba K; Onoguchi M; Kimura H; Hashimoto K; Odani A; Saji H
    Ann Nucl Med; 2009 Dec; 23(10):843-8. PubMed ID: 19921351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3]+ moiety (M = 99mTc, Re): synthesis, characterization, and biological behavior.
    Alves S; Paulo A; Correia JD; Gano L; Smith CJ; Hoffman TJ; Santos I
    Bioconjug Chem; 2005; 16(2):438-49. PubMed ID: 15769099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
    Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
    Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A newly designed radioimmunoconjugate releasing a hippurate-like radiometal chelate for enhanced target/non-target radioactivity.
    Arano Y; Matsushima H; Tagawa M; Inoue T; Koizumi M; Hosono M; Sakahara H; Endo K; Konishi J; Yokoyama A
    Nucl Med Biol; 1994 Jan; 21(1):63-9. PubMed ID: 9234265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
    van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and properties of antitumor monoclonal antibodies labeled with metallic radionuclides indium-111, gallium-67, and technetium-99m.
    Endo K; Sakahara H; Nakashima T; Koizumi M; Ohta H; Kawamura Y; Kunimatsu M; Furukawa T; Ohmomo Y; Arano Y
    NCI Monogr; 1987; (3):135-40. PubMed ID: 3469526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 99mTc labeling of proteins: initial evaluation of a novel diaminedithiol bifunctional chelating agent.
    Baidoo KE; Scheffel U; Lever SZ
    Cancer Res; 1990 Feb; 50(3 Suppl):799s-803s. PubMed ID: 2297727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
    Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
    Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of a novel (99m)tc-labeled annexin A5 for early detection of response to chemotherapy.
    Ogawa K; Ohtsuki K; Shibata T; Aoki M; Nakayama M; Kitamura Y; Ono M; Ueda M; Doue T; Onoguchi M; Shiba K; Odani A
    PLoS One; 2013; 8(12):e81191. PubMed ID: 24324676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facile synthesis and evaluation of C-functionalized benzyl-1-oxa-4,7,10-triazacyclododecane-N,N',N″-triacetic acid as chelating agent for ¹¹¹In-labeled polypeptides.
    Suzuki H; Kanai A; Uehara T; Guerra Gomez FL; Hanaoka H; Arano Y
    Bioorg Med Chem; 2012 Jan; 20(2):978-84. PubMed ID: 22178661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent.
    Karra SR; Schibli R; Gali H; Katti KV; Hoffman TJ; Higginbotham C; Sieckman GL; Volkert WA
    Bioconjug Chem; 1999; 10(2):254-60. PubMed ID: 10077475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.